New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2014
16:31 EDTDISH, LMCA, USB, XOM, BRK.B, MCO, COP, USG, WFC, BRK.A, GSK, STRZA, SU, DVA, LBTYABerkshire Hathaway gives quarterly update on stakes
NEW STAKES: Liberty Global (LBTYA). INCREASED STAKES: Wells Fargo (WFC), Exxon Mobil (XOM), Davita (DVA), USG (USG) and US Bancorp (USB). DECREASED STAKES: Suncor (SU), ConocoPhillips (COP), Liberty Media (LMCA), Starz (STRZA) and Moody's (MCO). LIQUIDATED STAKES: Dish Network (DISH) and GlaxoSmithKline (GSK).
News For B;LBTYA;WFC;XOM;DVA;USG;USB;SU;COP;LMCA;STRZA;MCO;DISH;GSK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 24, 2015
07:48 EDTUSBU.S. Bancorp volatility at high end of range
Subscribe for More Information
07:01 EDTWFCWells Fargo volatility at high end of range
Subscribe for More Information
06:14 EDTDVADaVita to acquire Renal Ventures for $415M
Subscribe for More Information
August 23, 2015
17:49 EDTXOM, COPIran to increase oil production as BP, Shell express interest, Bloomberg says
Subscribe for More Information
August 21, 2015
16:01 EDTXOMOptions Update; August 21, 2015
Subscribe for More Information
07:29 EDTUSGUSG management to meet with Sterne Agee CRT
Subscribe for More Information
05:25 EDTGSKNovartis acquires all remaining rights to Ofatumumab from GSK
Novartis (NVS) announced that it has entered into an agreement to acquire all remaining rights to Ofatumumab from GlaxoSmithKline (GSK). Ofatumumab, a fully human monoclonal antibody which targets CD20, is being developed for relapsing remitting multiple sclerosis, or RRMS, and other autoimmune indications. Novartis previously acquired the rights to Ofatumumab for oncology indications and it is marketed under the brand name Arzerra. Novartis will be responsible for the worldwide development, regulatory and commercialization activities for Ofatumumab. Under the terms of the agreement, Novartis will make an initial upfront payment of $300M to GSK for the acquisition of the compound and a further payment of $200M payable following the start of a phase III study in MS by Novartis. Upon completion of pre-determined milestones, contingent payments of up to $534M may be made. Novartis will also pay royalties of up to 12% to GSK on any future net sales of Ofatumumab in autoimmune conditions.
August 20, 2015
10:00 EDTUSBOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:25 EDTSUCanadian oil sands companies struggle from drop in crude prices, WSJ says
Subscribe for More Information
06:10 EDTXOM, COPAuction for drilling leases attracts little interest, NY Times reports
A federal auction for drilling leases in the Gulf of Mexico Wednesday attracted only $22.7M in sales from five companies, the lowest since 1986, reports the New York Times. Most companies have insisted they would not sacrifice production in future years, but executives have recently expressed concern that the oil price collapse could last through 2016 and possibly even 2017. Publicly traded companies in the space include BP (BP), Chevron (CVX), ConocoPhillips (COP), Exxon Mobil (XOM), Royal Dutch Shell (RDS.A) and Total (TOT). Reference Link
05:48 EDTWFCStocks with implied volatility movement; WFC XLI
Stocks with implied volatility movement; Wells Fargo (WFC) 16, Industrial Select Sector SPDR (XLI) 18 according to iVolatility.
August 19, 2015
17:12 EDTUSBU.S. Bancorp initiated with a Neutral at Sterne Agee CRT
Subscribe for More Information
16:58 EDTCOPOn The Fly: Top stock stories for Wednesday
The market opened deep in negative territory after a tumultuous trading session in China and a softer than expected U.S. consumer prices report. Sellers continued to push the averages lower throughout the morning, with the Dow tacking on losses of more than 200 points as investors waited for the release of the Fed minutes. The market rallied following an early leak of the minutes, which suggested officials are getting closer to raising rates but appear to be waiting for additional data. Despite the afternoon rally, the averages sold off once again heading into the close, leaving all three indices in the negatives for Wednesday. ECONOMIC EVENTS: In the U.S., the July consumer price index edged up 0.1% against expectations for 0.2% reading. The core reading, which excludes food and energy, also came in at 0.1% versus consensus estimates of 0.2%. There were no revisions to the 0.3% headline gain in June or the 0.2% growth in the ex-food and energy component. Component gains were muted across the board, with Energy prices up just 0.1% in July. Meanwhile, FOMC minutes showed no definitive indication of a September rate hike. Most committee members "judged that the conditions for policy firming had not yet been achieved, but they noted that conditions were approaching that point." Other members, however, believed that the inflation outlook "might not soon meet one of the conditions... for initiating a firming of policy." COMPANY NEWS: Shares of Dot Hill Systems (HILL) soared $4.50, or 86.87%, to $9.68 after Seagate Technology (STX) agreed to acquire the company for $9.75 per share, noting that it expects the deal to be non-GAAP EPS accretive in fiscal 2016. Shares of the hard drive giant fell 5.03% to $49.43 for the session... Lowe's (LOW) shares saw gains of $1.34, or 1.84%, to $74.36 following the company's earnings report this morning, while Target (TGT) rose $59c, or 0.73%, to $80.89 after beating on both top and bottom lines. On a subsequent conference call, Target executives forecast a "choppy" competitive environment in Q3, though they added that the company "will not get beat" on promotions in Q4. Separately, American Eagle (AEO) lost 7.42% to $16.92 after its quarterly numbers. MAJOR MOVERS: Among the notable gainers were Palatin (PTN) and Apricus (APRI), showing respective advances of 3.19% and 7.89% after the FDA approved Sprout's female sexual dysfunction drug Addyi, with the agency remarking that it "continues to encourage drug development in this area." Note that both Palatin and Apricus are developing their own treatments in the space, and Apricus reaffirmed this morning its intent to seek a global partner as it advances its Femprox sexual dysfunction medication. Also higher was Yum! Brands (YUM), which gained $1.90, or 2.26%, to $86.10 after appointing a new CEO of its China division, adding that its same-store sales in the region "have turned significantly positive." Among the noteworthy losers was Rayonier Advanced Materials (RYAM), plunging $6.01, or 44.09%, to $7.62 after disclosing a legal battle with its customer Eastman Chemical (EMN) over "meet or release" contract stipulations which may impact Eastman's purchase obligations. Also lower was Caesarstone (CSTE), which lost $3.43, or 7.14%, to $44.61 after short-selling hedge fund Spruce Point said the stock has up to 75% downside due to heightened raw material costs and competitive concerns, among other factors. Separately, EOG Resources (EOG), Baytex Energy (BTE), and Vanguard Natural (VNR) saw respective losses of 4.15%, 15.53%, and 13.83% after WTI crude fell 5.02% for the session. INDEXES: The Dow declined 162.61, or 0.93%, to 17,348.73, the Nasdaq fell 40.30, or 0.80%, to 5,019.05, and the S&P 500 lost 17.31, or 0.83%, to 2,079.61.
16:00 EDTXOMOptions Update; August 19, 2015
Subscribe for More Information
13:23 EDTCOPOptions with increasing call volume
Subscribe for More Information
10:20 EDTDISHBig telecom firms put M&A on hold, CTFN reports
Subscribe for More Information
August 18, 2015
17:35 EDTWFCWells Fargo to build additional car loan branches, Reuters says
Subscribe for More Information
10:17 EDTDISHDisney downgraded as Wells moves away from content providers
Subscribe for More Information
08:12 EDTCOPGlobal Big Oil sector upgraded at Citi
Citi analysts Alastair Syme and Michael Alsford upgraded their rating on the Global Big Oil space and now recommend investors position "at least a benchmark-weight" in the group. The analysts, who had been multi-year cautious on the space, prefer Total (TOT), ConocoPhillips (COP) and Statoil (STO), which they call "self-helpers." The sector price-to-book ratio of 1.2 times is now below the Q1 of 2009 and Q4 of 1998 troughs, Syme and Alsford write. Cost-cutting and better capital allocation are key to restoring the industry's profitability, they believe.
06:11 EDTDISHFCC: Dish can't apply $3.3B in credits in airwaves auction, AP reports
The FCC said that Dish Network may not apply $3.3B in small-business credits towards buying airwaves it acquired in a government auction, the Associated Press reports. Reference Link
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use